Literature DB >> 12501118

Measuring antianginal drug efficacy using exercise testing for chronic angina: improved exercise performance with ranolazine, a pFOX inhibitor.

Bernard R Chaitman1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12501118     DOI: 10.1067/mcn.2002.129438

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


× No keyword cloud information.
  2 in total

Review 1.  Ranolazine: a review of its use in chronic stable angina pectoris.

Authors:  M Asif A Siddiqui; Susan J Keam
Journal:  Drugs       Date:  2006       Impact factor: 9.546

2.  Ranolazine recruits muscle microvasculature and enhances insulin action in rats.

Authors:  Zhuo Fu; Lina Zhao; Weidong Chai; Zhenhua Dong; Wenhong Cao; Zhenqi Liu
Journal:  J Physiol       Date:  2013-06-24       Impact factor: 5.182

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.